Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia.
Preisler
H D
HD
Raza
A
A
Kukla
C
C
Larson
R
R
Goldberg
J
J
Browman
G
G
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015152:Blotting, Northern; D001853:Bone Marrow / Q000473:pathology; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D003630:Daunorubicin / Q000008:administration & dosage; D015870:Gene Expression; D006801:Humans; D007375:Interleukin-1 / Q000235:genetics*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D011379:Prognosis; D012074:Remission Induction; D014158:Transcription, Genetic
D007375:Interleukin-1; D003561:Cytarabine; D003630:Daunorubicin